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In addition to acute modulation of synaptic transmissionBrain-derived neurotrophic factor (BDNF) modulates
hippocampal plasticity and hippocampal-dependent and E-LTP, recent studies have demonstrated a role of
BDNF in long-term changes in hippocampal synapsesmemory in cell models and in animals. We examined
the effects of a valine (val) to methionine (met) substi- and L-LTP (Korte et al., 1998; Tartaglia et al., 2001).
Inhibition of BDNF signaling in rodents by gene knockouttution in the 5 pro-region of the human BDNF protein.
In human subjects, the met allele was associated with or infusion of antisense BDNF impairs spatial learning
and memory (Linnarsson et al., 1997; Minichiello et al.,poorer episodic memory, abnormal hippocampal acti-
vation assayed with fMRI, and lower hippocampal 1999; Mizuno et al., 2000). Despite substantial progress
in animal studies, BDNF’s relevance in human memoryn-acetyl aspartate (NAA), assayed with MRI spectros-
copy. Neurons transfected with met-BDNF-GFP showed and hippocampal function has not been examined di-
rectly.lower depolarization-induced secretion, while consti-
tutive secretion was unchanged. Furthermore, met- Unlike other growth factors, which are secreted pri-
marily via a constitutive pathway, at least in hippocam-BDNF-GFP failed to localize to secretory granules or
synapses. These results demonstrate a role for BDNF pal neurons, BDNF appears to be sorted into a regulated
pathway that secretes BDNF in response to neuronal
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structs demonstrate that BDNF is packaged into secre- of 641 subjects, including normal controls, patients with
schizophrenia, and their unaffected siblings, using mea-tory vesicles, which are transported to somatodendritic
compartments (Kojima et al., 2001). Activity-dependent sures from the Wechsler Memory Scale, revised version
(WMS-R), a test of verbal episodic memory. DelayedBDNF secretion from postsynaptic dendrites may serve
as a retrograde or paracrine messenger that regulates recall scores from the WMS-R reflect the amount of
information from two stories with 50 total elements thathippocampal LTP (Poo, 2001). Indeed, electric stimula-
tion of hippocampal neurons elicits BDNF-GFP secre- subjects are able to recall following a 0.5 hr delay. Pa-
tients with schizophrenia had substantially lower scorestion from dendrites (Hartmann et al., 2001). Taken to-
gether, these results strongly argue for a critical role of compared to controls, while siblings were intermediate
between these groups, consistent with earlier reportsactivity-dependent secretion of BDNF in hippocampus-
based synaptic plasticity and learning and memory. (Egan et al., 2001b; Figure 1A). In the entire sample,
BDNF genotype had a significant effect on these mem-Based on these experimental data, one might predict
that genetic interference of BDNF secretion would lead ory scores (F  3.89, df  2, 591, p  .02). In the group
of 133 controls alone, BDNF genotype also had a signifi-to deficits in hippocampal function, learning, and mem-
ory. The BDNF gene, like other peptide growth factors, cant effect on memory scores (F  5.04, df  2,130,
p  .008). While including patient and sibling groupsencodes a precursor peptide (proBDNF), which is pro-
teolytically cleaved to form the mature protein (Seidah did not substantially add to the results, both groups
showed the same effect seen in controls with met/metet al., 1996). Only one frequent, nonconservative poly-
morphism in the human BDNF gene (dbSNP number subjects tending to score lower than other genotype
groups (Figure 1A). Post hoc comparisons in the normalrs6265) has been identified, a single nucleotide polymor-
phism (SNP) at nucleotide 196 (G/A) producing an amino subjects alone showed that met/met homozygotes had
lower scores compared to val/val (p  .005) and val/acid substitution (valine to methionine) at codon 66 (val-
66met). We hypothesized that this SNP, though located met (p .052), while in the entire cohort, met/met homo-
zygotes had lower scores compared to the other twoin the 5 pro-BDNF sequence, and thus unlikely to alter
the intrinsic biological activity of the mature protein, genotype groups (p .007). Within each group (controls,
siblings, patients), each genotype group was wellwould affect intracellular processing and secretion of
BDNF, leading to impairments in hippocampal function matched on a variety of demographic parameters (see
Figure 1B), suggesting they did not account for the effectin humans. Because hippocampal dysfunction is associ-
ated with genetic risk for schizophrenia (Callicott et al., of BDNF genotype. Similar effects of BDNF genotype
were seen with immediate recall scores (of the stories1998; Egan et al., 2001a), we also hypothesized that
BDNF genotype might be associated with genetic risk described above) from the WMS-R (e.g., normal group,
F  3.65, df  2,130, p  .03). Post hoc comparisonsfor schizophrenia. To test these hypotheses, we exam-
ined first the effects of the BDNF val66met substitution in again showed that met/met homozygotes had lower
scores compared to val/val (p  .01) and val/met (p a cohort of normal controls, patients with schizophrenia
and their unaffected siblings, using three in vivo assays .07) groups.
BDNF genotype had no significant effect in either theof human hippocampal function: (1) cognitive measures
of episodic memory; (2) a neurophysiological measure normal subjects or the entire cohort on a second mem-
ory test which required recall of word lists, the Californiaof hippocampal activation during a memory task using
fMRI; and (3) an intracellular neurochemical measure of Verbal Learning Test (CVLT), immediately after hearing
the list (1–5 summary scores, F  0.79, df  2, 560; p hippocampal neuronal integrity and synaptic abundance
assayed with proton magnetic resonance spectroscopic .45; post hoc comparisons p  .14) and again 20 min
later (long delay free recall scores, F  0.23, df  2,imaging (1H-MRSI). To investigate underlying molecular
mechanisms, we transfected rodent hippocampal neu- 560; p  .79; post hoc comparisons p  .37). The CVLT
may have a larger “prefrontal component” (Kopelmanrons with val- or met-BDNF fused with GFP and exam-
ined trafficking of val- and met-BDNF proteins under et al., 1998) compared to the WMS-R, possibly reducing
hippocampal and val66met related variance. No effectfluorescence microscopy. We also determined constitu-
tive and regulated (i.e., depolarization-induced) BNDF of BDNF genotype was seen on other types of memory,
such as semantic memory (F  0.02, df  2, 591; p secretion in these neuronal cultures. Our analyses re-
vealed striking deficits in the cellular distribution and 98) or working memory/executive function (WCST, F 
0.33, df  2, 590; p  .71) (Figure 1B). These resultsregulated secretion of BDNF caused by this SNP and
corresponding alterations of human hippocampal func- suggest that the val66met polymorphism exerts its most
robust effects on episodic memory.tion in vivo. While we found no relationship between
BDNF genotype and schizophrenia, our results demon-
strate that BDNF plays a role in hippocampal function Effect of BDNF Genotype
and episodic memory in humans and provide insights on Hippocampal Activation
into the mechanisms for intracellular trafficking and se- To further characterize the effects of BDNF genotype,
cretion of BDNF. we performed an in vivo assay of hippocampal physiol-
ogy using the blood oxygenation level dependent
(BOLD) fMRI technique (Ogawa et al., 1992) in subjectsResults
performing the N-back working memory task. The brain
network subserving the N-back task (which is not aEffect of BDNF Genotype on Episodic Memory
In the first experiment, we examined the effects of BDNF test of episodic memory per se) is thought to involve
primarily neocortical regions, particularly dorsolateralgenotype on measures of episodic memory in a cohort
BDNF and Human Hippocampal Function
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Figure 1. Effect of BDNF val66met Genotype on Episodic Memory
(A) BDNF val66met genotype and episodic memory scores ( SE) from the WMS-R (delayed recall) in three samples studied.
(B) Demographic and cognitive data by genotype. Means ( SD) are presented. Genotype groups are well matched except for ap  .05, val/
val versus val/met.
prefrontal cortex (Callicott et al., 1999). However, these priate overactivation of val/met subjects in bilateral hip-
pocampus that were significant at the set level (p tasks also produce a robust and reliable deactivation or
disengagement of the hippocampus (Meyer-Lindenberg 0.05, c 2) (Figure 2A). To replicate this unusual finding,
we examined a second cohort of healthy subjects (pa-et al., 2001). Hippocampal deactivation has been re-
ported to be disrupted in clinical pathological states tients not included). Val/met subjects again showed an
abnormal pattern of increased bilateral hippocampal ac-(Callicott et al., 2000). We hypothesized, therefore, that
the BDNF met allele would disrupt the normal hippocam- tivation compared to baseline while val/val subjects
again showed deactivation. Direct comparison of thepal fMRI disengagement pattern during performance of
the N-back working memory task. two genotype groups again showed significant differ-
ences in hippocampal locales (Figure 2B).We studied two independent cohorts of healthy sub-
jects (patients were not included), each comprised of Because these healthy subjects were matched prior
to the experiment on task performance to remove thisval/met and val/val genotype subgroups; no met/met
subjects were included due to their low population fre- as a potential confounder, it cannot account for these
findings (Figure 2C). Within each cohort, genotypequency ( 5%). The members of the cohorts were se-
lected so that N-back performance, age, and gender groups were also matched on demographic variables,
suggesting they did not account for the BDNF effects.did not differ between the genotype subgroups. In the
first cohort, val/met individuals had an abnormal pattern One exception was a slight difference in full scale IQ
and WMS-R scores in the second cohort (Figure 2C).of increased activation of bilateral caudal hippocampus.
In contrast, val/val subjects showed the characteristic However, adding IQ as a covariate again revealed signifi-
cant bilateral clusters of differential caudal hippocampalhippocampal deactivation pattern. Directly comparing
val/val and val/met subjects showed this difference to be activation. To ensure the differences between groups
were not due to uneven sample sizes, all analyses werestatistically significant (see Figure 2). More specifically,
restricting the analysis to the medial temporal lobes also performed using subsets with the same number
of subjects in each genotype group. The results wererevealed two clusters of activation showing the inappro-
Cell
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Figure 2. Effect of BDNF val66met Genotype on In Vivo Hippocampal fMRI Response
(A) Brain map showing locales where BDNF genotype groups differed in blood oxygenation, an indirect measure of neuronal activity, measured
with fMRI during a working memory task. Regions marked in red are groups of voxels (“activation clusters”) where subjects with the val/met
genotype showed abnormal hippocampal activation and were significantly different when compared with val/val subjects (see Experimental
Procedures for statistical model). The statistical results are rendered on a canonical averaged T1 brain image and localized according to the
standard 3D stereotactic space of Talairach and Tournoux. The maximally activated voxels are: right hippocampus (t  3.77, p  0.01, cluster
size (k)  25, 3D coordinates: 26 22 –12); left hippocampus (t  2.39, p  0.02, k  10, 38 15 12). Inset: these activation clusters are
rendered on a canonical averaged smoothed 3D rendered brain. Color bar  T values. R  right hemisphere.
(B) BDNF genotype effect on hippocampal fMRI response in a second independent cohort. The activation clusters are those areas where
BDNF val/met subjects again showed abnormal activation of bilateral hippocampi locales during the 2 back working memory task and were
significantly different compared to val/val subjects. fMRI data rendered in the same manner as in (A) (p  0.05, cluster size  8.) Two clusters
were identified in the left hippocampus (30 35 16, t  2.49, p  0.01, k  40 and 30 14 13, t  2.45, p  0.01, k  13) and one in
the right hippocampus (28 31 2, t  2.55, p  0.01, k  37).
(C) Demographic and cognitive data for cohorts from (A) and (B) by genotype. Means ( SD) are presented. Genotype groups are well matched
except for ap  .05 and bp  .07 (covariance analyses revealed no effects of these differences on hippocampal activation patterns).
essentially identical. Scatter plots did not reveal outliers. abundance (Maier et al., 1995). Patients and siblings
both had lower NAA measures compared to controls,In summary, in two cohorts we found abnormal activa-
consistent with earlier studies (Callicott et al., 1998) (Fig-tion of hippocampus in val/met subjects compared to
ure 3A). A significant effect of BDNF val66met genotypethe normal pattern of deactivation in val/val subjects.
was found in the entire cohort (F  3.19, df  2, 280,Although this was seen in the context of a working mem-
p  .04), accounting for 1.9% of the overall varianceory task, which is typically more dependent on prefrontal
(Figure 3A). Post hoc comparisons indicated that hetero-function, and although the mechanism by which val66-
zygotes (val/met) had lower NAA levels compared tomet might produce this effect is uncertain, the data
val/val subjects (p .02). Using multiple regression anal-indicate that the BDNF met allele relative to val is associ-
ysis, a significant linear reduction in NAA levels withated with a qualitatively altered hippocampal response.
increasing number of met alleles was observed, indicat-
ing a possible allele dose effect (t(299)  2.29, p 
Effects of BNDF Genotype on In Vivo .02). BDNF genotype did not significantly affect right
n-acetyl-aspartate Measures hippocampal NAA measures, although, again individu-
We next examined the effects of val66met on an in vivo als with the met allele tended to have lower NAA signals
measure of neuronal/synaptic activity in the human hip- (val/val versus val/met, t  1.38, p  .17). ROI analyses
pocampal formation. NAA is an intracellular marker of of other brain regions (see Experimental Procedures)
neuronal function, related to mitochondrial oxidative showed no effect of BDNF genotype on NAA measures
phosphorylation (Jenkins et al., 2000) and appears to (data not shown). Within each genotype group, subjects
were well matched on demographic parameters (Figurebe an indirect measure of neuronal integrity and synaptic
BDNF and Human Hippocampal Function
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Figure 3. Effect of BDNF val66met Genotype on In Vivo Hippocampal NAA Measures
(A) BDNF val66met genotype and NAA measures in the left hippocampal formation ( standard error, SE) in three samples studied.
(B) Demographic data (means  SD) by genotype. Groups are well matched on all variables.
3B), suggesting they do not account for the effect of bodies (Figure 4B). The green fluorescence extended,
at best, to a few proximal dendrites. Quantitatively, theBDNF genotype. The results were similar in magnitude
(i.e., effect size) but statistically slightly weaker (F  number of GFP-bearing varicosities on distal dendrites
(within a 100 m diameter circle centered in the cell2.35, df  2,254, p  .097; val/val versus val/met p 
.04) in more restricted analyses of one ethnic group body) in mBDNF-expressing cells was dramatically re-
duced, compared to vBDNF-expressing cells (Figure 4C).alone (European Americans). Taken together, these re-
sults suggest that the val66met polymorphism elicits a Confocal microscopy showed that vBDNF-GFP ex-
hibited a striking punctate fluorescence, distributedspecific reduction in hippocampal neuronal integrity/
synaptic activity. throughout the cell body and extending to processes.
mBDNF-GFP neurons, however, exhibited a diffuse fluo-
rescence pattern mainly in cell bodies (Figure 5A). GreenVal- and Met-BDNF Expression in Cultured
fluorescence appeared to accumulate as a large patchHippocampal Neurons
in the peri-nuclear region. Quantitative analysis showedTo understand how val66met elicits the in vivo pheno-
a markedly reduced number of small fluorescence gran-types, we examined its impact on intracellular distribu-
ules, suggesting an impairment in regulated secretiontion, processing, and secretion of BDNF. We expressed
of BDNF protein in mBDNF cells.constructs containing either vBDNF or mBDNF, followed
by the green fluorescence protein (GFP), in cultured
neurons using the sindbis virus expression system (Fig- Secretion of val BDNF and met BDNF
We used a modified two-site immunoenzyme assay toure 4A). This approach allowed analysis of the expres-
sion, processing, biological activity, and release proper- measure vBDNF-GFP or mBDNF-GFP secretion from
virus-infected hippocampal neurons. To ensure thatties of the BDNF isoforms and to visualize their
distribution in living neurons (Hartmann et al., 2001; Ko- similar levels of vBDNF and mBDNF are expressed, we
performed Northern blot using a GFP cDNA probe. Nojima et al., 2001; Mowla et al., 1999). The viral titer was
controlled to 10% to avoid problems associated with differences in levels of BDNF-GFP mRNAs were de-
tected in hippocampal neurons infected with vBDNF-overexpression of exogenous proteins (Figure 6A). Fluo-
rescence microscopy revealed that vBDNF-GFP was GFP and mBDNF-GFP (Figure 6D). Moreover, Western
blot using an anti-GFP antibody indicated that levels oflocalized to the cell body and distal processes (Figure
4B). Double staining using an antibody against the den- mBDNF proteins in mBDNF-GFP transfected cells (both
the pro- and mature forms) were not different from thosedritic marker MAP2 showed that vBDNF-GFP fluores-
cence was mostly localized in dendrites (Figure 4B). In of vBDNF proteins in vBDNF-GFP transfected cells (Fig-
ure 6E).contrast, mBDNF-GFP was primarily localized in cell
Cell
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Figure 4. Abnormal Distribution of met BDNF
in Dendrites of Hippocampal Neurons
(A) Diagram of BDNF constructs. A cDNA
fragment for the entire coding sequence is
fused with cDNA for GFP. Arrow amino acid
66, which is val (vBDNF) or met (mBDNF).
(B) Representative low-power images of cul-
tured hippocampal neurons expressing
vBDNF-GFP or mBDNF-GFP. Twenty-four
hrs after transfection, neurons were pro-
cessed for MAP2 immunocytochemistry (red)
and GFP imaging (green). GFP images were
overexposed to improve visualization of GFP
in dendrites. vBDNF-expressing neurons ex-
hibit multiple labeled long processes while
mBDNF-expressing cells have fewer and
shorter labeled processes. Scale bar equals
10 m.
(C) Quantitation of BDNF dendritic expres-
sion. GFP-bearing varicosities (arrowheads in
B) on dendrites. N  50 neurons/genotype
group. In this and all remaining figures, data
are represented as means SE *: p  0.001,
student t test.
Conditioned media containing vBDNF-GFP or mBDNF- were washed, and the conditioned media were collected
2 hr later without high K. As shown in Figure 6C, secre-GFP were incubated in culture dishes precoated with
anti-GFP monoclonal antibody. After extensive washes, tion of BDNF was similar in cells infected with either
vBDNF-GFP or mBDNF-GFP. These data indicate thatlevels of secreted BDNF in the media were determined
by ELISA using an anti-BDNF antibody. vBDNF-GFP or the val66met polymorphism in the pro-region signifi-
cantly attenuated the activity-dependent form of BDNFmBDNF-GFP were virtually undetectable in a 10 min
incubation period (Figure 6B). Neuronal depolarization secretion without affecting its constitutive secretion.
Finally, we examined whether the properties of se-by high concentration of KCl (55 mM) for 10 min induced
a marked increase in vBDNF-GFP secretion (Figure 6B). creted mBDNF had been changed due to some unfore-
seen consequence of the variation in the pro-region.The concentration of vBDNF-GFP reached approxi-
mately 30 ng/ml in the conditioned medium. In contrast, COS cells were transfected with vBDNF-GFP or
mBDNF-GFP. The sizes of the precursor as well as ma-the activity-dependent release of mBDNF-GFP was se-
verely reduced and sometimes not detectable. Of those ture proteins did not differ, and the proBDNF-GFP/
BDNF-GFP ratios were similar in the two groups (Figureexperiments in which high K did induce detectable
release, the average concentration reached only 19 ng/ 7A). Moreover, the magnitude of induced TrkB phos-
phorylation, as detected by Western blot using antibodyml. We next investigated constitutive secretion in neu-
rons infected by vBDNF-GFP or mBDNF-GFP. Cultures against phosphorylated TrkB (pTrkB, Figure 7B), did not
BDNF and Human Hippocampal Function
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Figure 5. Abnormal Distribution of met BDNF
in Cell Body of Hippocampal Neurons
(A) Higher power images (3 per construct) of
cell body regions using confocal microscopy.
Signals for vBDNF are punctate and extend
into dendrites while those for mBDNF are dif-
fuse and concentrated in the peri-nuclear
region.
(B) Quantitation of fluorescent granules on
the cell body of transfected neurons. N  50
neurons in each genotype.
differ between vBDNF-GFP and mBDNF-GFP proteins. strongly suggest that met substitution for val in the pro-
region does not affect the structural and functional prop-Further, the two proteins elicited comparable biological
function, as measured by the neurite outgrowth assay erties of the mature protein.
using PC12 cells expressing TrkB receptors. Approxi-
mately 90% of the cells extended neurites longer than Subcellular Distribution of valBDNF-GFP
and metBDNF-GFPtheir cell bodies after treatment with BDNF or NGF, but
not conditioned media from mocked transfected cells. Differences in the distribution of vBDNF-GFP and
mBDNF-GFP and in the depolarization-induced secre-In cultures treated with vBDNF-GFP or mBDNF-GFP
proteins, similar percentage of the cells (90%) extended tion of the proteins further suggest that this mutation may
lead to errors in BDNF sorting into different secretoryneurites (Figure 7C). Taken together, these results
Figure 6. Activity-Dependent and Constitu-
tive Secretion of vBDNF and mBDNF
(A) Infection rate, as the percentage of MAP2-
positive neurons showing GFP fluorescence
(approximately 10% in both).
(B) Activity-dependent secretion is markedly
reduced in mBDNF-GFP neurons.
(C) Constitutive secretion. Amounts of
vBDNF-GFP or mBDNF-GFP secreted into
the media during 2 hr is similar. In (A–C), N 
4 independent experiments.
(D) Expression of vBDNF-GFP or mBDNF-
GFP mRNAs. Northern blot was performed
using total RNAs from neurons transfected
with vBDNF-GFP or mBDNF-GFP. Control:
RNA from untransfected cultures of the same
density. Equal amounts of RNAs (10 g) were
loaded in each lane. A GFP cDNA probe was
used to detect BDNF-GFP transcript (2 kb,
upper image), and the expression of NADPH
mRNA (1.7 kb, lower image) was used as the
loading control.
(E) Expression of vBDNF-GFP or mBDNF-
GFP proteins. Western blot probed with an
anti-GFP antibody using proteins from trans-
fected neurons. Equal amounts of proteins
(10 g) were loaded in each lane. Note that
vBDNF and mBDNF proteins are expressed
at the same level and processed in the same
way.
Cell
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Figure 7. Characterization of Secreted vBDNF and mBDNF
(A) Secretion of BDNF in COS cells expressing BDNF-GFP isoforms. Conditioned media from COS-7 cells transfected with vBDNF-GFP or
mBDNF-GFP genes were collected and concentrated. Note that the molecular weights of both pro- and mature proteins are similar in the
two groups. Moreover, the ProBDNF-GFP/BDNF-GFP ratios are similar in both groups, suggesting that mBDNF-GFP is successfully processed
and secreted.
(B) Activation of TrkB receptor by vBDNF-GFP and mBDNF-GFP. Cultured hippocampal neurons were treated for 5 min with the conditioned
media (100 ng/ml) derived from vBDNF-GFP, mBDNF-GFP, or mock-transfected COS-7 cells. Recombinant BDNF and BSA (50 ng/ml) were
used as positive and negative controls, respectively. Western blots were performed using an antibody against phospho-TrkB (pTrkB; upper
image) or TrkB (lower image).
(C) Effects of vBDNF-GFP and mBDNF-GFP on neurite outgrowth. PC12 cells expressing TrkB (PC12-pAB1) were cultured for three days in
the absence or presence of various factors. Upper image: examples of treated PC12-pAB1 cells. Lower image: quantitation of percentage of
neurite-bearing cells. The cells were treated with nothing (A), recombinant BDNF (B, 50 ng/ml), recombinant NGF (C, 50 ng/ml). Conditioned
media from mock transfected cells (D), or cells transfected with either vBDNF-GFP (E, 100 ng/ml) or mBDNF-GFP (F, 100 ng/ml) were also
used. Note that mBDNF-GFP exhibits the same biological activity as vBDNF-GFP.
pathways. To test this, we attempted to determine the that vBDNF-containing particles often superimposed
with punctate staining for the synapse marker synapto-subcellular localization of vBDNF-GFP and mBDNF-GFP
by double-staining techniques. Hippocampal neurons physin (Figure 8D). Although we cannot resolve whether
vBDNF is located pre- or postsynaptically at the lightexpressing vBDNF-GFP or mBDNF-GFP were stained
using antibodies for markers of intracellular organelles. microscopic levels, the synaptic localization of vBDNF
obviously would help its secretion locally at synapses.Some vBDNF-GFP and mBDNF-GFP signals colocalized
well with the Golgi marker TGN38, suggesting that both In marked contrast, mBDNF showed no colocalization
with synaptophysin (Figure 8D). Failure to localize atare successfully targeted into Golgi (Figure 8A). Many
fluorescent vBDNF-GFP particles, but not mBDNF-GFP synapses may contribute to the in vivo phenotypes as-
sociated with the val66met polymorphism.particles, were associated with the secretory vesicle
marker secretegranin II (SecII) (Figure 8B). This strongly
implies that met BDNF is not sorted from Golgi to secre- Discussion
tory granules. Both val BDNF and met BDNF failed to
colocalize with the large dense core marker chro- This study examines the role of BDNF in hippocampal
function and episodic memory in humans. Our strategymogranin A (CGA) (Figure 8C), indicating that BDNF-
containing particles are not large dense core vesicles. was to study the functional consequences of the only
reported common, single nucleotide polymorphism thatIn almost all cases, mBDNF-GFP formed large clusters
in the peri-nuclear region (Figures 8A–8C). While it is alters amino acid sequence in the pro-region of the
human BDNF gene. We have employed several in vivounclear to what subcellular constituents these clusters
belong, failures in sorting met BDNF into the appropriate approaches, including cognitive testing, fMRI, and 1H-
MRSI to demonstrate the impact of this polymorphismsecretory granules may explain the deficits in activity-
dependent secretion of met BDNF. Finally, it appeared on human brain function. We have also investigated
BDNF and Human Hippocampal Function
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Figure 8. Subcellular Localization of val BDNF and met BDNF in Hippocampal Neurons
Neurons infected with either vBDNF-GFP or mBDNF-GFP (green) were fixed and stained with various antibodies (red). The cell body region
of pyramidal neurons is shown in (A), (B), and (C). Scale bar equals 10 m.
(A) Golgi marker TGN38. Note that some vBDNF-GFP and mBDNF-GFP signals (yellow on Merged) are colocalized with TGN38.
(B) Secretory vesicle marker secretegranin II (SecII). Note the colocalization of vBDNF-GFP, but not mBDNF-GFP with SecII.
(C) Large dense core marker chromogranin A (CGA). Both vBDNF and mBDNF fail to colocalize with CGA.
(D) Synapse marker synaptophysin. Neuronal processes of a pyramidal cell are shown. Note that vBDNF punctates often colocalize with
synaptophysin while mBDNF does not colocalize at all.
potential molecular and cellular mechanisms underlying polymorphisms related to neurological disorders that
produce severe cognitive deficits, but their relevancethe biological effects of this polymorphism, using virus-
mediated transfection of val BDNF or met BDNF into for normal human cognition is unclear (de Geus et al.,
2001). One exception is the ApoE gene, a variant ofcultured hippocampal neurons. The in vivo experiments
provide converging evidence that BDNF plays a role in which (ApoE4) increases risk for Alzheimer’s disease
(Roses, 1998) and may exert a negative effect on cogni-human verbal episodic memory as well as hippocampal
neuronal integrity and physiological activation. The in tion and physiology even in unaffected subjects (Book-
heimer et al., 2000).vitro data suggest that the val66met substitution im-
pacts activity-dependent secretion of BDNF. These re- The current study has several unique features. First,
we focus on the normal range of cognition in a cohortsults are important for several reasons. First, they dem-
onstrate the feasibility of studying, in vivo, the effects including healthy, middle aged subjects. Second, a spe-
cific polymorphism in a promising candidate gene isof specific genes on hippocampal biology and memory.
Second, they show that variation within the normal range selected and examined using multiple clinical neurobio-
logical methods. The results provide converging evi-of human verbal episodic memory involves BDNF signal-
ing, suggesting that the basic molecular mechanisms dence for a specific genetic effect on hippocampal neu-
rochemistry, physiology, and cognition. Third, cellularof LTP and spatial memory in lower species have been
conserved in the more highly evolved verbal episodic and molecular biological approaches are used to ad-
dress the underlying mechanisms. This combined ap-memory of humans. Third, the results implicate a spe-
cific genetic polymorphism as a factor in altered human proach provides direct in vivo data that the molecular
mechanisms related to activity dependent BDNF secre-hippocampal function, which is therefore likely to have
an impact on susceptibility to or expression of illnesses tion and signaling, such as LTP and synaptic plasticity,
may underlie the human ability to form memories. Thisthat involve hippocampal neuronal integrity. Finally, the
present data also reveal the importance of the pro- approach is probably generalizable to many other genes
and cognitive processes. It is also worth emphasizingregion of the BDNF polypeptide, particular val66 and
perhaps the nearby sequence, in intracellular trafficking that these results demonstrate the remarkable power of
fMRI methods to detect specific genetic effects withand secretion of BDNF.
Cognitive aspects of human brain function have been substantially lower numbers of subjects than are re-
quired for more complex human phenotypic measureslargely inaccessible to direct molecular experimental
approaches. Limited data have come from pharmaco- (see also Egan et al., 2001b; Hariri et al., 2002).
Our results also speak to a current debate about thelogical challenge studies (Mattay et al., 1996), but this
approach has been constrained by the relative paucity genetics of human intelligence. Specific cognitive abili-
ties are partially correlated, and the extent of this corre-of drugs and their regional and molecular nonspecificity,
compared with the number of genes likely involved in lation is referred to as “g”, synonymous with IQ. Much
genetic epidemiological data suggest that the geneticcognition. More recently, genetic studies have identified
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determinants of different cognitive abilities largely over- is small. This is expected, given the likely polygenic
genetic architecture of these functions. However, thelap with each other and with IQ. In other words, genes
influence specific cognitive traits by virtue of their “top convergence of data using three in vivo methods and the
replication of fMRI findings in two independent cohortsdown” effects on g (Plomin, 1999). The alternative “bot-
tom up” view that genes contribute to IQ primarily argues strongly that the BDNF effect is at the level of
hippocampal function. Similarly, studies of heterozygotethrough their unique and more direct effects on specific
cognitive modules has found little support. The present BDNF knockout rodents, who presumably have interme-
diate BDNF levels, demonstrate clear physiologicaldata are consistent with the latter formulation. We did
not detect an effect of BDNF on IQ or any other cognitive (Korte et al., 1995) and behavioral (Lyons et al., 1999)
abnormalities, suggesting that secretion levels are criti-ability (although we did not examine some other types
of memory, such as priming, skill and habit acquisition, cal. A second caveat applies to genetic studies in gen-
eral whereby spurious results can arise when ethnicand fear conditioning). A recent study of the role of the
COMT gene on working memory and prefrontal physiol- groups are mixed (“population stratification”). Because
we see identical effects in one ethnic group alone (Euro-ogy, but not IQ, provides further evidence for this view
(Egan et al., 2001b). While COMT and BDNF may ulti- pean Americans) and because similar effects are seen in
both the normal controls and our schizophrenia families,mately be shown to exert small effects on IQ, our current
data suggest that their effects are somewhat specific stratification is unlikely to explain our results (Wacholder
et al., 2000). Third, genetic association per se cannotand mediated through “modular” cognitive elements.
exclude a potential effect of another nearby polymor-
phism in linkage disequilibrium with val66met. We rese-Cellular Processing of BDNF
quenced the BDNF coding region in 16 subjects (32An unusual aspect of BDNF as a neurotrophic molecule
chromosomes) and scanned for other polymorphismsis its secretion via both constitutive and regulated path-
in 66 subjects. Only one rare synonymous change wasways (Goodman et al., 1996; Mowla et al., 1999). Activity-
observed, suggesting linkage disequilibrium to a nearbydependent secretion of BDNF makes it an attractive
locus does not account for these results. The demon-candidate for mediating various forms of synaptic plas-
stration that the met allele is both associated with rela-ticity, such as hippocampal LTP (Katz and Shatz, 1996).
tively poorer human hippocampal function and impairedBDNF secreted in response to transient or sustained
intracellular trafficking and regulated secretion arguesneuronal activity is likely to participate in acute modula-
strongly that the effects in humans are due specifically totion of synaptic transmission or long-term regulation
the met allele. Finally, the BDNF val66met polymorphismof synaptic structures and functions, respectively. It is
may have important implications for clinical medicine.therefore critical to understand the molecular mecha-
While we did not find evidence that BDNF was associ-nisms that control activity-dependent BDNF secretion.
ated with increased risk for schizophrenia, the met alleleWe show that depolarization-dependent secretion of
may affect other human illnesses. Impaired memory andBDNF in hippocampal neurons is significantly impaired
hippocampal function is present in many human disor-when val66 in the proBDNF sequence is replaced with
ders, including Alzheimer’s disease (Morris et al., 2001),a met. This might be due to the inability of met BDNF to
head trauma, various psychiatric conditions, and evenbe sorted from Golgi to appropriate secretory granules.
normal aging. Because the distribution of hippocampalThus, our study identifies the pro-region of BDNF, partic-
function in met/met subjects is shifted downward, suchularly the val66 and adjacent regions, as an important
patients may suffer greater functional impairment.molecular determinant for intracellular sorting and ac-
In conclusion, we have demonstrated that an aminotivity-dependent secretion of this molecule. Finally, us-
acid altering polymorphism at codon 66 in the BDNFing double-staining techniques, we demonstrated val
gene affects intracellular distribution, packaging, andBDNF-containing secretory granules are colocalized
release of the BDNF protein in vitro. Furthermore, inwith synaptophysin, a marker for synapses. In contrast,
humans, this polymorphism has significant effects onmet BDNF aggregates are accumulated in the cell body
verbal episodic memory, hippocampal physiological ac-and rarely colocalize with synaptophysin. This result
tivation, and measures of hippocampal neuronal integ-suggests that even if it can be secreted in small amounts
rity and synaptic abundance. These convergent datanear the cell body through the constitutive pathway, the
suggest that, similar to animal models, BDNF plays amet BDNF protein cannot be secreted at synapses. This
role in human episodic memory by virtue of its effectsmay hamper local and synapse-specific regulation by
on hippocampal neuronal function. Inheritance of theBDNF, leading to impairments in hippocampal function
BDNF met allele might be expected to confer suscepti-and episodic memory in humans. Of course, the pro-
bility to or modify the expression of conditions that im-posed cellular mechanism is based on transfection of
pact adversely on hippocampal function. Finally, be-artificial constructs alone and the effects of val66met on
cause the relatively deleterious met allele, which hasin vivo hippocampal BDNF targeting/secretion remain
not been observed in lower primates, remains in theuncertain. Thus, our conclusion that these defects con-
human genome, it may confer some compensatory ad-tribute to impairments in human hippocampal activity
vantage in other biological processes.and memory must be viewed as tentative.
Experimental ProceduresClinical Caveats and Implications
Several caveats about our clinical data are worth em- Human Subjects
phasizing. First, the magnitude of the effects of BDNF Subjects were recruited from the Clinical Brain Disorders Branch
“sibling study” of schizophrenia and included healthy controls,genotype on in vivo measures of hippocampal function
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schizophrenic probands, and their mostly unaffected siblings (age were reported as ratios of the area under the peaks for NAA/CRE,
NAA/CHO, and CHO/CRE. Hippocampal formation (inclusive of18–60; ethnicity was 6.3% African American, 89.8% European Amer-
ican, and 3.9% other) (Egan et al., 2000). Applicants were screened amygdala, hippocampus, entorhinal cortex, and parahippocampal
gyrus) and other regions of interest (dorsolateral prefrontal cortex,for factors that could impact brain function, such as head trauma,
etc. Availability of the MRI scanner was the only factor determining putamen, caudate, cingulate, thalamus, and superior temporal gy-
rus) were examined (Bertolino et al., 1996).whether MRSI and fMRI were performed.
Cognitive Testing
Genetic AnalysisSubjects performed an extensive cognitive test battery (Egan et
BDNF val66met genotype was determined using the Taqman 5-al., 2001a). Two tests dependent on episodic memory included the
exonuclease assay (details available on request). To validate geno-Wechsler Memory Scale, revised version (WMS-R) and the California
typing results, relevant amplicons from 75 subjects were sequencedVerbal Learning Test (CVLT), standard tests of medial temporal lobe
and were identical to those generated from Taqman. The frequen-function. To reduce comparisons, WMS-R delayed recall scores
cies of the two BDNF alleles were 0.81 for val and 0.19 for met.were chosen as the primary outcome measure, as these scores
Genotype frequencies (val/val  0.67, val/met  0.28, met/met were most strongly related to genetic risk for schizophrenia in this
0.05) were in Hardy Weinberg equilibrium. There were no differencescohort. Data from Logical Memory I, CVLT 1-5 summary scores,
between individual groups in allele or genotype frequencies. In theand long delay free recall scores are also described. IQ and reading
cohort with schizophrenia, no overtransmission of either allele fromcomprehension (using the WRAT) were also included to control for
parents to affected offspring was seen in a family based transmis-general intelligence. Exploratory analyses of other types of memory
sion disequilibrium analysis. HPLC variant scanning of exons andwere performed using the Wisconsin Card Sorting Test (WCST), a
splice sites in 66 subjects of various val66met genotypes and rese-test of working memory/executive function (perseverative errors T
quencing of the coding open reading frame in 16 subjects revealedscores) and verbal fluency for categories, a measure of semantic
no other sequence variants, except a rare synonymous F63F.memory (Egan et al., 2001a).
Functional Magnetic Resonance Imaging Statistical Analyses
We examined hippocampal function using fMRI in two cohorts of Effects of genotype on cognitive measures and NAA were assessed
healthy right-handed subjects (#1:8 val/vals and 5 val/mets; #2: 12 using ANOVA. For analyses that included families, we used mixed
val/vals and 5 val/mets, including 5 unrelated healthy subjects from effects ANOVA. Effects of demographic factors were examined us-
the family cohort). The N-back was used as a cognitive challenge; ing ANOVA or regression and included as main effects or covariates
normal subjects show robust hippocampal deactivation (Callicott in BDNF analyses when significant. To avoid population stratifica-
et al., 2000). We used a block design, alternating between two back tion, all analyses were performed on the entire cohort and subjects
(“2B”; subjects must recall a number [1, 2, 3, or 4] seen two stimuli from one ethnic group (the largest, European Americans); the latter
previously) and a control condition (“0B”; subjects identified the are reported only if different from the former.
number currently seen) (Callicott et al., 2000). Within each cohort,
subjects for each genotype group were matched on N back perfor-
mance to remove possible variance due to performance. Thus, dif- Cell Cultures and Neurite Growth Assay
ferences in the fMRI data presumably reflect variation in how the Dissociated cultures of hippocampal neurons were prepared using
information is processed in brain, not in overt behavior. embryonic day 20 rats (E20, Wistar ST) as described (Kojima et
For the first cohort, whole brain BOLD fMRI data were collected al., 2001). Neurons were maintained in Neurobasal medium (Gibco)
on a 3 Tesla GE scanner using a GE-EPI RT pulse sequence (GE, containing 0.1% horse serum, 2% B27 supplement (Gibco), and 0.5
Milwaukee, WI). For the second cohort, whole brain BOLD fMRI data mM L-glutamine (Sigma) for 6–8 days. Polyethyleneimine-coated
were collected at 1.5 Tesla (GE, Milwaukee, WI) using a gradient- glass-bottomed chambers (Matsunami, surface area, 1.5 cm2 ) were
echo fast spiral acquisition. All fMRI data were processed as de- used for imaging, and 12-well culture plates (Coster) were used for
scribed previously (Callicott et al., 2000). Single subject contrast BDNF immunoassay, Northern, and Western blots. Stable TrkB-
maps were created by contrasting 2B and 0B using a 1 sample expressing PC12 cells, PC12-pAB1 (Nakatani et al., 1998) were cul-
T-test (p  0.05, corrected). All individual maps showed activation tured in collagen-coated glass-bottomed chambers in Neurobasal
of the typical WM network. medium containing 2% B27 and 0.5 mM L-glutamine. Cells were
To determine the effect of BDNF genotype, group data were ana- treated with conditioned media or 50 ng/ml BDNF for 4 days. Neurite
lyzed in two steps. First, a within genotype group analysis tested outgrowth was assayed by calculating the percentage of cells bear-
for voxels showing significant changes (p  0.05, cluster size  8 ing neurites longer than the cell body (Kojima et al., 2001).
voxels, uncorrected) in BOLD signal in the two versus zero back
condition for each subject. The use of a cluster size  8 increases
the statistical threshold for significance to p 0.0001. These voxels Sindbis Virus Construction and Infection
were pooled for each genotype group. Second, pooled voxels were vBDNF was cloned in pEGFP-N1 plasmid (Clontech) between EcoRI
used for between group comparisons. A bounding box created a and BamHI sites. The val to met mutation in the met BDNF construct
priori (details on request) was used to select only voxels within was generated by replacing the BstBI and SapI fragment containing
the hippocampal ROI (identical to a region of interest approach). the val66 sequence with a mutant dsDNA cassette (CGAACACAT-
Between group comparisons were performed as a second level top and ATCACGTGTT-bottom strands) containing the met66 se-
(random effects) one-way ANOVA within SPM 99 (p  0.05 uncor- quence. Recombinant sindbis virus was constructed according to
rected, cluster size [k]  8) (Figure 2A). Coordinates for statistically the Invitrogen manual. Each BDNF-GFP construct was inserted into
significant activation clusters were converted back to the standard the multiple cloning site of sindbis vector pSinRep5. The RNAs of
space of Talairach and Tournoux and reported as the local maxima. pSinRep5-BDNF-GFP and helper DH (26S) were electroporated into
BHK cells. The pseudovirions-containing medium (55DME) was col-
lected 36 hr later. Sindbis virus infection of hippocampal neurons1H Magnetic Resonance Spectroscopic Imaging (MRSI)
1H-MRSI was performed on a GE-SIGNA 1.5 Tesla MR scanner as was performed as described (Osten et al., 2000) with minor modifica-
tions. The titer of the infection was determined by the percentagein earlier reports (Bertolino et al., 1996). The 1H-MRSI slices were
positioned parallel to the sylvian fissure and encompassing the hip- of cells expressing GFP fluorescence. Cultured neurons were in-
fected at a titer of 10% for five hours, followed by a 24 hr incubationpocampal formation as visualized on T1 weighted MRI scans. Each
volume element (“voxel”) had nominal dimensions of 7.5 mm 	 7.5 in B27-containing Neurobasal medium. COS-7 cells were infected
with the sindbis virus containing the vBDNF-GFP or mBDNF-GFPmm 	 15 mm (0.84 mL). To produce metabolite maps, location and
integration of the signal strength of N-acetyl-aspartate compounds gene for 24 hr at a titer of 100%, followed by a 24 hr incubation in
DMEM containing L-glutamine (500 M). The conditioned media(NAA), creatine plus phosphocreatine (CRE), and choline-containing
compounds (CHO) was automatically computed. Metabolite signals were collected and concentrated by Centriplus (Millipore).
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